Related Experiment Videos

Altering vessel wall fatty acid metabolism: a new strategy for antithrombotic treatment

M R Buchanan¹, S J Brister

¹Department of Pathology, McMaster Clinic, Hamilton General Hospital, Ontario, Canada.

Seminars in Thrombosis and Hemostasis

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Successful allogeneic stem cell transplant after invasive pulmonary zygomycosis.

Leukemia & lymphoma·2002

Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro.

Thrombosis and haemostasis·2001

Results of the BRAT study--a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery.

The Canadian journal of cardiology·2000

Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.

Thrombosis research·2000

A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.

Wiener klinische Wochenschrift·1999

Cardiopulmonary bypass pumps and thrombin generation: what goes around comes around.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1998

See all related articles